TYR Tyratech (DI/S)

TIDMTYR TIDMTYRU

RNS Number : 6566D

TyraTech, Inc.

01 April 2014

1 April 2014

TyraTech, Inc.

("TyraTech" or the "Company")

Vamousse(TM) head lice treatment available at over 4,000 Walmart stores in the USA

Further to its 14 January 2014 announcement, TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focusing on nature-derived insect and parasite control products, is pleased to confirm its breakthrough head lice treatment product, Vamousse(TM), is now available in more than 4,000 Walmart stores in the USA.

Bruno Jactel, Chief Executive Officer, said: "The Board is very pleased that we are currently on schedule both in terms of number of stores and timings of sales for our Vamousse(TM) head lice treatment, with products already selling in the USA. We are confident this roll-out will greatly raise the profile of Vamousse(TM)."

Further information on Vamousse(TM) is available on the Company's website at: http://www.tyratech.com/content/company-products/head-lice.asp

For further information please contact:

 
TyraTech Inc. 
 Alan Reade, Non-Executive Chairman Tel: +44 78 4197 8709 
 Bruno Jactel, Chief Executive Officer Tel: +1 919 415 4340 
SPARK Advisory Partners Limited, Nominated Adviser 
 Matt Davis / Mark Brady Tel: +44 20 3368 3551 
 
 Allenby Capital Limited, Joint Broker 
 Chris Crawford Tel: +44 20 3328 5656 
Whitman Howard, Joint Broker 
 Ranald McGregor-Smith/ Niall Devins Tel: 44 20 7087 4550 
 
 Walbrook, Financial PR and IR 
 Bob Huxford /Guy McDougall (Public Relations) Tel: +44 20 7933 8792 
 Paul Cornelius (Investor Relations) Tel: +44 20 7933 8794 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCWGUWAWUPCGQG

Tyratech (LSE:TYR)
Historical Stock Chart
From Jun 2024 to Jul 2024

Tyratech (LSE:TYR)
Historical Stock Chart
From Jul 2023 to Jul 2024